Correlation between endothelin-1 and atherosclerosis in chronic hemodialysis patients

Journal of Nephrology

Volumn 23, Issue 5, 2010, Pages 593-602

  Liu, Hong ^a   Peng, Youming ^a   Liu, Fuyou ^a   Liu, Yinghong ^a   Ouyang, Lin ^a   Xiao, Weiwei ^a   Cheng, Meichu ^a   Chen, Xing ^a   Gao, Lei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Atherosclerosis; ET 1; Hemodialysis; Intima media thickness; Plaque score

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIN 1; INTERLEUKIN 6; LIPID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERNAL ILIAC ARTERY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; SCORING SYSTEM;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; ENDOTHELIN-1; FEMALE; HUMANS; ILIAC ARTERY; INTERLEUKIN-6; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 78049427104     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis. 1992;19:505-513.
2. Suwelack B, Witta J, Hausberg M, Muller S, Rahn K-H, Barenbrock M. Studies on structural changes of the carotid arteries and the heart in asymptomatic renal transplant recipients. Nephrol Dial Transplant. 1999;14:160-165.
3. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58:353-362. (Pubitemid 30429882)
4. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983-1992.
5. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
6. Murch SH, Braegger CP, Sessa WC, et al. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis. Lancet. 1992;339:381-385.
7. Benigni A, Remutti G. Endothelin antagonists. Lancet. 1999;353:133-138.
8. Barton M, Haudenschild CC, d'Uscio LV, et al. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 1998;95:14367-14372.
9. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation. 2005;111:363-368.
10. Zeiher AM, Goebel H, Schächinger V, et al. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 1995;91:941-947.
11. Ihling C, Göbel H, Lippoldt A, et al. Endothelin-1-like- immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J Pathol. 1996;179:303-308.
12. Rossi GP, Colonna S, Pavan E, et al. Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo. Circulation. 1999;99:1147-1155.
13. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM. Coexpression of endothelinconverting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation. 2001;104:864-869. (Pubitemid 32778034)
14. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997-1001.
15. Hong S. Study of the quantitative method of immunohistochemistry(III). Chinese Journal of Histochemistry and Cytochemistry. 1995; 4: 89-91.
16. Lundblad R, Moen O, Fosse E. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1997;63:1361-1367.
17. Savage T, Clarke AL, Giles M, Tomson CRV, Raine AEG. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant. 1998;13:2004-2012.
18. Masaki T. Historical review: endothelin. Trends Pharmacol Sci. 2004;25:219-224.
19. Böhm F, Ahlborg G, Pernow J. Endothelin-1 inhibits endothelium dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin Sci (Lond). 2002;102:321-327. (Pubitemid 34214395)
20. Galle J, Lehmann-Bodem C, Hubner U, Heinloth A, Wanner C. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation. Nephrol Dial Transplant. 2000;15:339-346.
21. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65:1009-1016.
22. Böhm F, Settergren M, Pernow J. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis. 2007;190:408-415.
23. Mann CD, Metcalfe MS, Nicholson ML. Normothermic perfusion of ischaemic porcine kidneys: an evaluation of ex vivo function and endothelin receptor antagonism. J Nephrol. 2009;22:144-151.
24. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199-204.
25. Ohkuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohashi H. C-reactive protein, lipoprotein (a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis. 2003;42:355-361. (Pubitemid 36944445)
26. Bologa RM, Levine DM, Parker ST, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am J Kidney Dis. 1998;32:107-114.
27. Stenvinkel P, Heimbürger O, Lindholm B, et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis(MIA syndrome). Nephrol Dial Transplant. 2000;15:953-960.
28. Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002;105:1890-1896.
29. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
30. Brull DJ, Leeson CP, Montgomery HE, et al. The effect of the interleukin-6-174G
31. Browatzki M, Schmidt J, Kubler W, et al. Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-κB in human vascular smooth muscle cells. Basic Res Cardiol. 2000;95:98-105. (Pubitemid 30251265)